Clinical Trial Update: Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of anakinra in corticosteroid-resistant sudden sensorineural hearing loss was terminated; results were posted in December 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Sensorineural Hearing Loss

Drugs mentioned

• KINERET (ANAKINRA)

Snippet

Sponsor: Andrea Vambutas | Conditions: Hearing Loss, Sudden | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-12-05